TELEMEDICINE IN RHEUMATOLOGY: ACCEPTANCE BY PATIENTS AND MEDICAL PRACTITIONERS IN GERMANY (TELERHEUMABB) - INTERIM ANALYSIS (2020) Muehlensiepen F, Marquardt W, Knitza J, Hueber A, Welcker M Conference contribution NO INCREASED RISK OF FALLS IN PATIENTS TREATED WITH BIOLOGICS COMPARED TO THOSE UNDER CSDMARDS (2020) Rudi T, Schaefer M, Manger B, Zink A, Strangfeld A Conference contribution FIBROBLAST GROWTH FACTOR RECEPTOR 3 REGULATES THE ACTIVITY OF PROFIBROTIC CYTOKINE AND GROWTH FACTOR PATHWAYS TO DRIVE FIBROBLAST ACTIVATION AND TISSUE FIBROSIS IN SYSTEMIC SCLEROSIS (2020) Chakraborty D, Zhu H, Juengel A, Summa L, Li YN, Bergmann C, Matei AE, et al. Conference contribution ADAPTOR PROTEINS ACTIVATE FIBROBLASTS IN SYSTEMIC SCLEROSIS (2020) Ariza Y, Weber S, Neise N, Kreuter A, Schett G, Distler J, Ramming A Conference contribution INNATE LYMPHOID CELLS INDUCE A FIBROTIC PHENOTYPE OF FIBROBLASTS (2020) Weber S, Anchang CG, Rauber S, Luber M, Raimondo MG, Ariza Y, Rigau AR, et al. Conference contribution STRUCTURAL ENTHESEAL LESIONS IN PSORIASIS PATIENTS ARE ASSOCIATED WITH AN INCREASED RISK OF PROGRESSION TO PSORIATIC ARTHRITIS - A PROSPECTIVE COHORT STUDY (2020) Simon D, Tascilar K, Kleyer A, Bayat S, Kampylafka E, Hueber A, Rech J, et al. Conference contribution PREDICTION OF FLARES FOR RHEUMATOID ARTHRITIS PATIENTS ON BIOLOGIC DMARDS USING MACHINE LEARNING AND SUBSETS OF VARIABLES AVAILABLE TO PHYSICIANS, PATIENTS AND PAYERS (2020) Vodencarevic A, Tascilar K, Hartmann F, Reiser M, Bayat S, Knitza J, Valor L, et al. Conference contribution FINE STRUCTURE ANALYSIS OF THE INTER-RELATION BETWEEN TOPHUS DEPOSITION AND BONE LESIONS IN GOUT USING A COMBINATION OF DUAL ENERGY AND HIGH-RESOLUTION CT (2020) Bayat S, Simon D, Pecherstorfer C, Ellmann H, Figueiredo C, Englbrecht M, Hueber A, et al. Conference contribution COMPARISON OF INFLAMMATION DURING METABOLIC CHANGES IN RHEUMATOID AND OSTEOARTHRITIS MOUSE MODELS (2020) Sauermilch HM, Hulser ML, Schreiyaeck C, Luo Y, Bozec A, Schett G, Mueller-Ladner U, Neumann E Conference contribution INHIBITION OF HSP90 REDUCES PROGRESSION OF DERMAL FIBROSIS AND INDUCES REGRESSION OF ESTABLISHED EXPERIMENTAL DERMAL FIBROSIS INDUCED BY BLEOMYCIN (2020) Storkanova H, Storkanova L, Oreska S, Spiritovic M, Hermankova B, Becvar R, Pavelka K, et al. Conference contribution